SG Americas Securities, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$485
-37.7%
4,761
-44.4%
0.00%
-55.6%
Q1 2023$778
+194.7%
8,558
+23.1%
0.01%
+200.0%
Q4 2022$264
-99.9%
6,952
-13.8%
0.00%0.0%
Q3 2022$203,000
-25.6%
8,067
-10.1%
0.00%0.0%
Q2 2022$273,000
+108.4%
8,976
+80.2%
0.00%
+200.0%
Q4 2021$131,000
-90.4%
4,981
-63.3%
0.00%
-83.3%
Q3 2021$1,364,000
+171.7%
13,561
+282.4%
0.01%
+200.0%
Q2 2021$502,000
+160.1%
3,546
+83.6%
0.00%
+100.0%
Q1 2021$193,000
-85.5%
1,931
-82.0%
0.00%
-85.7%
Q4 2020$1,327,000
+57.0%
10,736
+23.8%
0.01%
+40.0%
Q3 2020$845,000
+46.2%
8,675
+134.2%
0.01%0.0%
Q2 2020$578,000
-30.4%
3,704
-35.6%
0.01%
-37.5%
Q1 2020$830,000
+49.5%
5,750
+111.7%
0.01%
+60.0%
Q4 2019$555,000
+130.3%
2,716
+6.4%
0.01%
+150.0%
Q2 2019$241,000
-4.0%
2,553
-13.0%
0.00%0.0%
Q1 2019$251,000
+46.8%
2,936
-4.0%
0.00%
+100.0%
Q4 2018$171,0003,0570.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders